4D Molecular Therapeutics...

NASDAQ: FDMT · Real-Time Price · USD
7.28
0.18 (2.54%)
At close: Aug 15, 2025, 3:59 PM
7.23
-0.62%
After-hours: Aug 15, 2025, 07:58 PM EDT

4D Molecular Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-1.87 -7.86 -7.11 -8.91
PEG Ratio
-0.12 0.45 -0.26 -0.56
PS Ratio
8.12K 38.26 229.63 33.73
PB Ratio
0.59 2.58 -2.28 -2.94
P/FCF Ratio
-2.17 -10.09 -7.32 -7.78
P/OCF Ratio
-2.23 -10.46 -8.29 -8.8
OCF/S Ratio
-3.64K -3.66 -27.7 -3.83
Debt / Equity Ratio
0.05 0.05 -0.05 -0.08
Quick Ratio
14.92 15.65 14.39 19.83
Current Ratio
14.92 15.65 14.02 19.31
Asset Turnover
0.00 0.06 0.01 0.05
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-0.32 -0.33 0.32 0.33
Return on Assets
-0.29 -0.3 -0.39 -0.19
Return on Invested Capital
-0.35 -0.35 -0.41 -0.2
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
1.00 -3.69 -0.24 0.83
Net Profit Margin
-4.35K -4.87 -32.3 -3.79
Pretax Profit Margin
-4.35K -4.87 -34.35 -3.95
Operating Profit Margin
-5.08K -5.45 -35.17 -3.95
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-5.08K -5.17 -33.93 -3.79